var data={"title":"Epidemiology, etiology, and prevention of cerebral palsy","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, etiology, and prevention of cerebral palsy</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/contributors\" class=\"contributor contributor_credentials\">Elizabeth Barkoudah, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/contributors\" class=\"contributor contributor_credentials\">Laurie Glader, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/contributors\" class=\"contributor contributor_credentials\">Marc C Patterson, MD, FRACP</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/contributors\" class=\"contributor contributor_credentials\">Carolyn Bridgemohan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/contributors\" class=\"contributor contributor_credentials\">Carrie Armsby, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 12, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cerebral palsy (CP) refers to a heterogeneous group of conditions involving permanent nonprogressive central motor dysfunction that affect muscle tone, posture, and movement. These conditions are due to abnormalities of the developing fetal or infantile brain resulting from a variety of causes. Although the disorder itself is not progressive, the clinical expression may change over time as the brain matures. The motor impairment generally results in limitations in functional abilities and activity which can range in severity. Multiple additional symptoms often accompany the primary motor abnormalities, including altered sensation or perception, intellectual disability, communication and behavioral difficulties, seizure disorders, and musculoskeletal complications. Although the underlying etiology itself is not progressive, the clinical expression may change over time as the brain matures.</p><p>The epidemiology, etiology, and prevention of CP are reviewed here. The classification, clinical features, evaluation, diagnosis, management, and prognosis of CP are discussed separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-features-and-classification-of-cerebral-palsy\" class=\"medical medical_review\">&quot;Clinical features and classification of cerebral palsy&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=evaluation-and-diagnosis-of-cerebral-palsy\" class=\"medical medical_review\">&quot;Evaluation and diagnosis of cerebral palsy&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=management-and-prognosis-of-cerebral-palsy\" class=\"medical medical_review\">&quot;Management and prognosis of cerebral palsy&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H338437633\"><span class=\"h2\">Prevalence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The overall prevalence of CP is approximately 2 per 1000 live births [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/1-5\" class=\"abstract_t\">1-5</a>]. The prevalence of CP is far higher in preterm compared with term infants, and increases with decreasing gestational age (GA) and birth weight (BW) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/1,2,6\" class=\"abstract_t\">1,2,6</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GA:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>GA &lt;28 weeks: 82 per 1000 live births</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>GA 28 to 31 weeks: 43 per 1000 live births</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>GA 32 to 36 weeks: 6.8 per 1000 live births</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>GA &gt;36 weeks: 1.4 per 1000 live births</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>BW:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&lt;1500 g: 59.2 per 1000 live births</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>1500 to 2499 g: 10.2 per 1000 live births</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&gt;2500 g: 1.33 per 1000 live births</p><p/><p>Although infants born preterm are at higher risk of developing CP, preterm infants account for less than half of cases of CP. In large epidemiologic studies of children with CP, approximately 25 percent were very preterm (GA &lt;32 weeks); 10 to 20 percent were moderately preterm or late preterm (GA 32 to 36 weeks); and 60 percent were born at term (GA &gt;36 weeks) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/2,7\" class=\"abstract_t\">2,7</a>].</p><p class=\"headingAnchor\" id=\"H338437639\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to prematurity and BW, which are the most important risk factors for developing CP, numerous other prenatal and perinatal factors have been reported to be associated with an increased risk of CP (<a href=\"image.htm?imageKey=PEDS%2F102940\" class=\"graphic graphic_table graphicRef102940 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/2,7-12\" class=\"abstract_t\">2,7-12</a>]; however, in many cases causal relationships have not been established. Potentially modifiable prenatal factors that may contribute to CP risk include heavy maternal alcohol consumption, maternal smoking, maternal obesity, and infections during pregnancy [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/13-18\" class=\"abstract_t\">13-18</a>]. CP is most often multifactorial and multiple risk factors coexist. (See <a href=\"#H3\" class=\"local\">'Etiology'</a> below.)</p><p class=\"headingAnchor\" id=\"H338437646\"><span class=\"h2\">Trends over time</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the 1960s through 1980s, the rate of CP and the extent of disability among preterm infants increased as survival improved for the most immature [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/19\" class=\"abstract_t\">19</a>]. During the 1980s and 1990s, there was a reversal in this trend, most likely because of improvements in perinatal care. In one study, the prevalence of CP among very low birth weight (VLBW; &lt;1500 g) infants declined from 60.6 per 1000 live births in 1980 to 39.5 per 1000 live births in 1996 [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/20\" class=\"abstract_t\">20</a>]. This improvement occurred despite overall increases in survival and multiple births and decreases in mean BW among this group. In another study, the prevalence of CP among preterm infants (GA 20 to 27 weeks) decreased from 155 per 1000 live births in the early 1990s (1992 to 1994) to 16 per 1000 live births in the early 2000s (2001 to 2003) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/21\" class=\"abstract_t\">21</a>]. This was in the setting of stable or decreasing mortality during the same time period.</p><p>Among term and late preterm infants, the prevalence of CP remained stable during the 1980s and 1990s [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/22\" class=\"abstract_t\">22</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The etiology of CP is multifactorial. Most cases are thought to be due to prenatal factors, but peri- and postnatal factors or events can also result in CP. Prematurity is the most common association; however, in many cases, no cause is identified [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/23\" class=\"abstract_t\">23</a>].</p><p>The multifactorial etiology was illustrated in a series of 213 children diagnosed with CP in Australia [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/24\" class=\"abstract_t\">24</a>]. Major CP-associated pathologies other than acute intrapartum hypoxia were identified in 98 percent of cases; some children had more than one associated pathology:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prematurity (78 percent)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intrauterine growth restriction (34 percent)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intrauterine infection (28 percent)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antepartum hemorrhage (27 percent)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe placental pathology (21 percent)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple pregnancy (20 percent)</p><p/><p>Common causes of CP are described below. The associated causes differ somewhat based upon the subtype of CP (<a href=\"image.htm?imageKey=PEDS%2F74533\" class=\"graphic graphic_table graphicRef74533 \">table 2</a>).</p><p class=\"headingAnchor\" id=\"H16406295\"><span class=\"h2\">Prematurity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CP develops in approximately 5 to 15 percent of surviving preterm very low birth weight (VLBW; BW &lt;1500 g) infants [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/1,6\" class=\"abstract_t\">1,6</a>]. In this population, CP is often associated with the following conditions [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/25\" class=\"abstract_t\">25</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Periventricular leukomalacia (PVL) &ndash; PVL refers to necrosis of cerebral white matter in a specific distribution, dorsolateral to the external angles of the lateral ventricles and involving the region adjacent to the trigones and to the frontal horn and body of the lateral ventricles. In addition to perinatal inflammation and other etiologies discussed above, cerebral ischemia in a specific distribution contributes to PVL and leads to CP in preterm infants. (See <a href=\"topic.htm?path=germinal-matrix-hemorrhage-and-intraventricular-hemorrhage-gmh-ivh-in-the-newborn-prevention-management-and-complications#H172645315\" class=\"medical medical_review\">&quot;Germinal matrix hemorrhage and intraventricular hemorrhage (GMH-IVH) in the newborn: Prevention, management, and complications&quot;, section on 'White matter injury'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intraventricular hemorrhage (IVH) &ndash; Severe IVH, periventricular hemorrhagic infarction, and posthemorrhagic hydrocephalus (a potential complication of IVH) may lead to CP [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=germinal-matrix-hemorrhage-and-intraventricular-hemorrhage-gmh-ivh-in-the-newborn-pathogenesis-clinical-presentation-and-diagnosis\" class=\"medical medical_review\">&quot;Germinal matrix hemorrhage and intraventricular hemorrhage (GMH-IVH) in the newborn: Pathogenesis, clinical presentation, and diagnosis&quot;</a> and <a href=\"topic.htm?path=germinal-matrix-hemorrhage-and-intraventricular-hemorrhage-gmh-ivh-in-the-newborn-prevention-management-and-complications\" class=\"medical medical_review\">&quot;Germinal matrix hemorrhage and intraventricular hemorrhage (GMH-IVH) in the newborn: Prevention, management, and complications&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bronchopulmonary dysplasia (BPD) &ndash; The risk of motor impairment is greater in preterm infants affected by BPD. The mechanism is not known but may involve the use of corticosteroids to improve lung disease. This issue is discussed in greater detail separately. (See <a href=\"topic.htm?path=outcome-of-infants-with-bronchopulmonary-dysplasia#H10\" class=\"medical medical_review\">&quot;Outcome of infants with bronchopulmonary dysplasia&quot;, section on 'Neurodevelopment outcome'</a> and <a href=\"topic.htm?path=postnatal-use-of-corticosteroids-in-bronchopulmonary-dysplasia\" class=\"medical medical_review\">&quot;Postnatal use of corticosteroids in bronchopulmonary dysplasia&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Perinatal hypoxic-ischemic injury</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although it is often suspected as a cause, perinatal hypoxia <span class=\"nowrap\">and/or</span> ischemia likely accounts for only a small minority of cases of CP [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/27-30\" class=\"abstract_t\">27-30</a>]. Reports of the proportion of CP cases caused by birth asphyxia vary from &lt;3 to &gt;50 percent depending on the definition of birth asphyxia used [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/30\" class=\"abstract_t\">30</a>]. In a study using the criteria set forth by the American College of Obstetricians and Gynecologists (ACOG) and the International Cerebral Palsy Task Force (<a href=\"image.htm?imageKey=NEURO%2F96192\" class=\"graphic graphic_table graphicRef96192 \">table 3</a>), an acute intrapartum hypoxic event was identified in only 1 percent (2 of 213 infants) of children with CP [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/24,31\" class=\"abstract_t\">24,31</a>]. (See <a href=\"topic.htm?path=etiology-and-pathogenesis-of-neonatal-encephalopathy#H575903726\" class=\"medical medical_review\">&quot;Etiology and pathogenesis of neonatal encephalopathy&quot;, section on 'Acute events'</a>.)</p><p>When severely damaging perinatal hypoxia occurs, it presents as neonatal encephalopathy, which is a heterogeneous, clinically defined syndrome characterized by disturbed neurologic function in the earliest days of life in an infant born at term, manifested by a subnormal level of consciousness or seizures, often accompanied by difficulty with initiating and maintaining respiration and depression of tone and reflexes [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-neonatal-encephalopathy\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of neonatal encephalopathy&quot;</a>.)</p><p>Neonates with severe intrapartum hypoxia-ischemia may have seizures, coma, hypotonia, dysfunction of other organ systems, a persistently low Apgar score, and evidence of profound metabolic acidosis. On magnetic resonance imaging (MRI), two main patterns of hypoxic-ischemic injury are seen: basal <span class=\"nowrap\">ganglia/thalamic</span> predominant pattern and a watershed predominant pattern (<a href=\"image.htm?imageKey=PEDS%2F100474\" class=\"graphic graphic_diagnosticimage graphicRef100474 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/32\" class=\"abstract_t\">32</a>]. Perinatal hypoxia-ischemia also can cause necrosis in the spinal cord gray matter, contributing to flaccidity, hypokinesia, and absent reflexes [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/33\" class=\"abstract_t\">33</a>].</p><p>Infants with CP caused by an acute intrapartum hypoxic-ischemic event are more likely to have spastic quadriparesis or dyskinetic CP than other subtypes of CP. (See <a href=\"topic.htm?path=clinical-features-and-classification-of-cerebral-palsy#H1479191130\" class=\"medical medical_review\">&quot;Clinical features and classification of cerebral palsy&quot;, section on 'CP subtypes'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Congenital abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital abnormalities, particularly structural central nervous system (CNS) abnormalities, are more common in children with than without CP [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/8,34-37\" class=\"abstract_t\">8,34-37</a>]. In a population-based case-control study, congenital CNS abnormalities occurred in 14 percent of children with CP and 1 percent of controls [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/8\" class=\"abstract_t\">8</a>]. The proportions of non-CNS abnormalities were similar in the two groups.</p><p>Intrapartum events may be influenced by a preexisting abnormality [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/38,39\" class=\"abstract_t\">38,39</a>]. In one report, birth defects (mostly non-CNS anomalies) occurred more often in term infants with neonatal encephalopathy than in controls (28 versus 4 percent) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/40\" class=\"abstract_t\">40</a>]. The birth defect was considered the cause of the encephalopathy in approximately one-third of affected infants. Infants with birth defects who had encephalopathy were three times more likely to have CP than those without.</p><p>In children with CP due to brain malformations, the biologic basis is usually unknown. Some result from abnormalities that occur during brain development and affect cell proliferation, migration, differentiation, survival, or synaptogenesis. Disorders of development occasionally result from exposure to radiation, toxins, or infectious agents during a critical period of gestation [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/41-44\" class=\"abstract_t\">41-44</a>]. Some disorders (eg, schizencephaly) are genetic and follow Mendelian inheritance patterns [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/45-49\" class=\"abstract_t\">45-49</a>]. Certain cerebral malformations can also be associated with chromosomal abnormalities (eg, holoprosencephaly is associated with both trisomy 13 and 18). Some neurocutaneous syndromes are associated with brain malformations (eg, hemimegalencephaly and hypomelanosis of Ito or the linear sebaceous nevus syndrome) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/50\" class=\"abstract_t\">50</a>]. (See <a href=\"topic.htm?path=prenatal-diagnosis-of-cns-anomalies-other-than-neural-tube-defects-and-ventriculomegaly#H14\" class=\"medical medical_review\">&quot;Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly&quot;, section on 'Schizencephaly'</a> and <a href=\"topic.htm?path=prenatal-diagnosis-of-cns-anomalies-other-than-neural-tube-defects-and-ventriculomegaly#H3\" class=\"medical medical_review\">&quot;Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly&quot;, section on 'Holoprosencephaly'</a> and <a href=\"topic.htm?path=congenital-cytogenetic-abnormalities#H14\" class=\"medical medical_review\">&quot;Congenital cytogenetic abnormalities&quot;, section on 'Trisomy 13 syndrome'</a> and <a href=\"topic.htm?path=congenital-cytogenetic-abnormalities#H11\" class=\"medical medical_review\">&quot;Congenital cytogenetic abnormalities&quot;, section on 'Trisomy 18 syndrome'</a> and <a href=\"topic.htm?path=the-genodermatoses#H29839266\" class=\"medical medical_review\">&quot;The genodermatoses&quot;, section on 'Neurocutaneous syndromes'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Genetic susceptibility</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Genetic disorders were historically thought to be uncommon causes of CP, but with the advent of novel genomic testing techniques, they are increasingly recognized as playing an important role in the etiology of CP [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/51-53\" class=\"abstract_t\">51-53</a>]. In addition, the aggregation of CP in groups with high consanguinity and observations of increased familial risk for CP suggests a genetic contribution to CP risk [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/54-56\" class=\"abstract_t\">54-56</a>].</p><p>In a study using whole exome sequencing in 183 patients with CP, 14 percent had a potentially disease-causing gene variant, de novo or inherited [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/57\" class=\"abstract_t\">57</a>]. In a study of 52 children with nonprogressive CP without an identified etiology, genomic testing with chromosomal microarray analysis identified clinically significant copy number variations in 31 percent [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/58\" class=\"abstract_t\">58</a>].</p><p>Several genetic polymorphisms have been associated with susceptibility for CP, including apolipoprotein E [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/59,60\" class=\"abstract_t\">59,60</a>], genes associated with thrombophilia (eg, prothrombin <em>G20210A</em> mutation) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/61,62\" class=\"abstract_t\">61,62</a>], and genes involved with inflammation (eg, inducible nitric oxide synthetase, lymphotoxin alpha, and certain cytokines) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/63,64\" class=\"abstract_t\">63,64</a>]. However, only the association with prothrombin <em>G20210A</em> mutation was confirmed by a subsequent large study [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/62\" class=\"abstract_t\">62</a>]. (See <a href=\"topic.htm?path=prothrombin-g20210a-mutation\" class=\"medical medical_review\">&quot;Prothrombin G20210A mutation&quot;</a>.)</p><p>Hereditary spastic paraplegia (HSP) is a diverse group of neurologic disorders that range in phenotype and inheritance pattern [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/65,66\" class=\"abstract_t\">65,66</a>]. HSP is characterized by progressive lower extremity spasticity. More than 50 corresponding genes have been linked to HSP. HSP is discussed in greater detail separately. (See <a href=\"topic.htm?path=hereditary-spastic-paraplegia\" class=\"medical medical_review\">&quot;Hereditary spastic paraplegia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Multiple births</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of CP is increased among multiple births [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/67-72\" class=\"abstract_t\">67-72</a>]. Causes that may contribute to this risk include low BW, prematurity, congenital anomalies, cord entanglement, and abnormal vascular connections [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/73\" class=\"abstract_t\">73</a>]. In a study of births in Western Australia from 1980 to 1989, the prevalence of CP was 1.6, 7.3, and 28 per 1000 survivors to one year of age in singletons, twins, and triplets, respectively [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/67\" class=\"abstract_t\">67</a>]. In this report, the increased rates of CP in multiples were limited to infants of normal BW, although multiples were more likely to have low BW.</p><p>Death of a co-twin greatly increases the risk of CP. In the report from Western Australia, the risk of CP among twins was greater when one twin died in utero (96 versus 12 per 1000 twin pairs) compared with both surviving [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/67\" class=\"abstract_t\">67</a>]. The mechanism may include release of thromboplastin and emboli from the dead twin, causing injury to the survivor. It is possible that some cases of CP in apparent singletons may be due to an unrecognized fetal death of a co-twin [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/74\" class=\"abstract_t\">74</a>].</p><p>Postnatal death also increases the risk of CP in the surviving co-twin and monozygosity appears to influence this risk. In a study that analyzed birth and death certificate data (1993 to 1995) for different sex (dizygotic) and same sex (dizygotic and monozygotic) twins, and assessed disability in surviving twins after neonatal death of the co-twin using questionnaires sent to clinicians, the risk of CP was greater in same sex compared with different sex twin survivors (167 versus 21 per 1000) for infants of BW 1000 to 1999 g, although the difference was only marginal for infants of BW &lt;1000 g (224 versus 200 per 1000) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/75\" class=\"abstract_t\">75</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Stroke</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Stroke in the perinatal period contributes to CP, especially spastic hemiparesis. Thromboembolism and prothrombotic disorders contribute to the etiology of this disorder. Lesions typically are identified by cranial imaging studies following a neonatal seizure. However, some newborns with stroke are asymptomatic until hemiparesis or other abnormalities develop later in infancy or childhood. (See <a href=\"topic.htm?path=clinical-features-and-classification-of-cerebral-palsy#H16407646\" class=\"medical medical_review\">&quot;Clinical features and classification of cerebral palsy&quot;, section on 'Early signs of CP'</a>.)</p><p>Prenatal causes include hypercoagulable states, vasculopathies, abnormal development of blood vessels, and emboli secondary to disorders affecting the placenta or fetus [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/76\" class=\"abstract_t\">76</a>]. Stroke that occurs during early infancy may be caused by sepsis, disseminated intravascular coagulation, venous sinus thrombosis, emboli, and congenital heart disease [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/77,78\" class=\"abstract_t\">77,78</a>]. Some cases are caused by periventricular atrophy or cerebral dysgenesis. Affected patients with nondiagnostic neuroimaging may have maldevelopment at a microscopic level [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/79,80\" class=\"abstract_t\">79,80</a>]. (See <a href=\"topic.htm?path=stroke-in-the-newborn-classification-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stroke in the newborn: Classification, manifestations, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Intracranial hemorrhage</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intracranial hemorrhage (ICH) in term infants is unusual, but frequently results in neuromotor abnormalities. Most are recognized because of the sudden and dramatic onset of symptoms, including seizures, abnormal movements, apnea, lethargy, irritability, vomiting, and bulging fontanelle. Diagnosis is made by cranial imaging.</p><p>The incidence depends in part upon the method of ascertainment. In one series of 33 term infants with symptomatic ICH, the regional incidence was estimated to be 0.27 per 1000 live births [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/81\" class=\"abstract_t\">81</a>]. Approximately one-third of cases were related to coagulopathies. In another report, ICH was diagnosed by ultrasound scan in 54 of 2019 term infants (2.7 percent) treated in a newborn intensive care unit (ICU) from 1989 to 1999 [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/82\" class=\"abstract_t\">82</a>]. Neurologic impairment developed in 28 percent.</p><p>Thalamic hemorrhage with residual germinal matrix hemorrhage is a common source of ICH in this population. When no source is apparent, the ICH is thought to originate from the choroid plexus. In one report, thalamic hemorrhage was identified in 12 of 19 term infants younger than one month of age with ICH diagnosed by computed tomography (CT) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/83\" class=\"abstract_t\">83</a>]. Thalamic hemorrhage typically occurred in infants with uneventful birth histories and presentation after one week of age. Many had predisposing factors for cerebral vein thrombosis (eg, sepsis, congenital heart disease, coagulopathy, electrolyte disturbance). At 18 months of age, the majority had CP, predominantly hemiplegia, and other neurologic abnormalities such as hydrocephalus and seizures.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Intrauterine infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intrauterine infection is associated with an increased risk of CP. Congenital infections with organisms such as cytomegalovirus, syphilis, Zika virus, varicella virus, and toxoplasmosis play a role. Bacterial infections are also associated with CP. (See <a href=\"topic.htm?path=overview-of-torch-infections\" class=\"medical medical_review\">&quot;Overview of TORCH infections&quot;</a> and <a href=\"topic.htm?path=congenital-cytomegalovirus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Congenital cytomegalovirus infection: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=congenital-zika-virus-infection-clinical-features-evaluation-and-management-of-the-neonate\" class=\"medical medical_review\">&quot;Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate&quot;</a> and <a href=\"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">&quot;Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants&quot;</a>.)</p><p>Maternal chorioamnionitis is associated with an increased risk of CP in term infants [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/84-86\" class=\"abstract_t\">84-86</a>]. A 2000 meta-analysis of 26 observational studies found that both clinical and histologic chorioamnionitis were associated with increased risk of CP (relative risk [RR] 1.9, 95% CI 1.5-2.5) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/87\" class=\"abstract_t\">87</a>]. Another systematic review in 2003 had similar findings [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/88\" class=\"abstract_t\">88</a>] and a subsequent case-control study also reported a strong association between maternal chorioamnionitis and CP (odds ratio [OR] 4.1, 95% CI 1.6-10.1) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/86\" class=\"abstract_t\">86</a>]. Another case-control study found that any maternal infection during pregnancy was associated with increased risk of CP (OR 2.9, 95% CI 1.7-4.8) and that neonatal infection was a strong independent predictor of CP (OR 14.7, 95% CI 1.7-126.5) [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/89\" class=\"abstract_t\">89</a>].</p><p>In preterm infants, perinatal infection appears to play a key role in the pathogenesis of PVL and subsequent CP [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/90\" class=\"abstract_t\">90</a>]. (See <a href=\"#H16406295\" class=\"local\">'Prematurity'</a> above.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Acquired postnatal causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While most cases are due to prenatal or perinatal factors, CP can also result from insults to the developing brain acquired during infancy and early childhood. Approximately 10 to 18 percent of cases of CP are acquired after the neonatal period [<a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/9\" class=\"abstract_t\">9</a>]. Most of these patients have spastic CP. Common causes of postnatally-acquired CP include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stroke &minus; Stroke is uncommon in infants and children and is usually associated with an underlying disorder (eg, congenital heart disease, prothrombotic disorder, sickle cell disease, vasculopathy, or metabolic disorder). Stroke typically results in spastic hemiparesis. (See <a href=\"topic.htm?path=stroke-in-the-newborn-classification-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stroke in the newborn: Classification, manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=ischemic-stroke-in-children-and-young-adults-etiology-and-clinical-features\" class=\"medical medical_review\">&quot;Ischemic stroke in children and young adults: Etiology and clinical features&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Trauma. (See <a href=\"topic.htm?path=child-abuse-evaluation-and-diagnosis-of-abusive-head-trauma-in-infants-and-children\" class=\"medical medical_review\">&quot;Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe hypoxic events such as near-drowning. (See <a href=\"topic.htm?path=drowning-submersion-injuries#H8\" class=\"medical medical_review\">&quot;Drowning (submersion injuries)&quot;, section on 'Neurologic'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sepsis or meningitis. (See <a href=\"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">&quot;Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants&quot;</a> and <a href=\"topic.htm?path=bacterial-meningitis-in-the-neonate-neurologic-complications\" class=\"medical medical_review\">&quot;Bacterial meningitis in the neonate: Neurologic complications&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Kernicterus &minus; Infants with severe hyperbilirubinemia are at risk for kernicterus, permanent neurologic sequelae of bilirubin-induced neurotoxicity (BIND) that manifests itself as a type of CP characterized by choreoathetosis, with gaze abnormalities and sensorineural hearing loss. The disorder results when unconjugated bilirubin enters the brain and causes focal necrosis of neurons and glia. The regions most often affected include the basal ganglia and the brainstem nuclei for oculomotor and auditory function, accounting for the clinical features of this condition. (See <a href=\"topic.htm?path=clinical-manifestations-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants#H5\" class=\"medical medical_review\">&quot;Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants&quot;, section on 'Kernicterus'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other causes of encephalopathy. (See <a href=\"topic.htm?path=etiology-and-pathogenesis-of-neonatal-encephalopathy\" class=\"medical medical_review\">&quot;Etiology and pathogenesis of neonatal encephalopathy&quot;</a> and <a href=\"topic.htm?path=acute-toxic-metabolic-encephalopathy-in-children#H2966690529\" class=\"medical medical_review\">&quot;Acute toxic-metabolic encephalopathy in children&quot;, section on 'Specific etiologies of encephalopathy'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">PREVENTION</span></p><p class=\"headingAnchor\" id=\"H16405152\"><span class=\"h2\">Antenatal measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antenatal measures to reduce the likelihood of CP include provision of routine prenatal care, including measures to reduce the likelihood of preterm birth. (See <a href=\"topic.htm?path=prenatal-care-initial-assessment\" class=\"medical medical_review\">&quot;Prenatal care: Initial assessment&quot;</a> and <a href=\"topic.htm?path=prenatal-care-second-and-third-trimesters\" class=\"medical medical_review\">&quot;Prenatal care: Second and third trimesters&quot;</a> and <a href=\"topic.htm?path=preterm-birth-risk-factors-and-interventions-for-risk-reduction\" class=\"medical medical_review\">&quot;Preterm birth: Risk factors and interventions for risk reduction&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H16405165\"><span class=\"h3\">Magnesium sulfate</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is increasing evidence from clinical trials that antenatal administration of <a href=\"topic.htm?path=magnesium-sulfate-pediatric-drug-information\" class=\"drug drug_pediatric\">magnesium sulfate</a> to women at risk for preterm birth decreases the incidence and severity of CP in their offspring, without affecting mortality. This issue is discussed in greater detail separately. (See <a href=\"topic.htm?path=neuroprotective-effects-of-in-utero-exposure-to-magnesium-sulfate\" class=\"medical medical_review\">&quot;Neuroprotective effects of in utero exposure to magnesium sulfate&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4234399981\"><span class=\"h2\">Intrapartum measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Delaying umbilical cord clamping for at least 30 to 60 seconds after birth in vigorous infants has been shown to reduce the risk of intraventricular hemorrhage in preterm infants and may be associated with improved neurodevelopmental outcomes. This issue is discussed in greater detail separately. (See <a href=\"topic.htm?path=management-of-normal-labor-and-delivery#H30\" class=\"medical medical_review\">&quot;Management of normal labor and delivery&quot;, section on 'Cord clamping'</a>.)</p><p class=\"headingAnchor\" id=\"H16405158\"><span class=\"h2\">Postnatal measures</span></p><p class=\"headingAnchor\" id=\"H16405196\"><span class=\"h3\">Supportive measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Supportive neuroprotective measures for neonates at risk of neurologic injury (ie, preterm very low birth weight [VLBW] infants and infants with neonatal asphyxia <span class=\"nowrap\">and/or</span> encephalopathy) are aimed at reducing the likelihood of long-term neurodevelopmental sequelae and include (see <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-neonatal-encephalopathy#H8678465\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of neonatal encephalopathy&quot;, section on 'Supportive management'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maintaining adequate ventilation (see <a href=\"topic.htm?path=mechanical-ventilation-in-neonates\" class=\"medical medical_review\">&quot;Mechanical ventilation in neonates&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maintaining sufficient cerebral perfusion (see <a href=\"topic.htm?path=etiology-clinical-manifestations-evaluation-and-management-of-neonatal-shock\" class=\"medical medical_review\">&quot;Etiology, clinical manifestations, evaluation, and management of neonatal shock&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maintaining normal metabolic status (see <a href=\"topic.htm?path=fluid-and-electrolyte-therapy-in-newborns\" class=\"medical medical_review\">&quot;Fluid and electrolyte therapy in newborns&quot;</a> and <a href=\"topic.htm?path=management-and-outcome-of-neonatal-hypoglycemia\" class=\"medical medical_review\">&quot;Management and outcome of neonatal hypoglycemia&quot;</a> and <a href=\"topic.htm?path=neonatal-hyperglycemia#H15\" class=\"medical medical_review\">&quot;Neonatal hyperglycemia&quot;, section on 'Management'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Controlling seizures (see <a href=\"topic.htm?path=treatment-of-neonatal-seizures\" class=\"medical medical_review\">&quot;Treatment of neonatal seizures&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treating any underlying causes for encephalopathy (eg, infection or metabolic derangements) (see <a href=\"topic.htm?path=management-and-outcome-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">&quot;Management and outcome of sepsis in term and late preterm infants&quot;</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-bacterial-sepsis-in-the-preterm-infant-less-than34-weeks-gestation\" class=\"medical medical_review\">&quot;Treatment and prevention of bacterial sepsis in the preterm infant (&lt;34 weeks gestation)&quot;</a> and <a href=\"topic.htm?path=inborn-errors-of-metabolism-metabolic-emergencies\" class=\"medical medical_review\">&quot;Inborn errors of metabolism: Metabolic emergencies&quot;</a>)</p><p/><p/><p class=\"headingAnchor\" id=\"H16405171\"><span class=\"h3\">Therapeutic hypothermia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For term or late preterm infants with neonatal asphyxia <span class=\"nowrap\">and/or</span> encephalopathy, therapeutic hypothermia improves survival and neurodevelopmental outcome at 18 months. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-neonatal-encephalopathy#H16\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of neonatal encephalopathy&quot;, section on 'Therapeutic hypothermia'</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The prevalence of cerebral palsy (CP) is approximately 2 cases per 1000 children. The risk is markedly increased among preterm infants with low birth weight (BW). (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The etiology of CP is multifactorial. Most cases are thought to be due to prenatal factors. The most commonly identified prenatal risk factors for CP are prematurity <span class=\"nowrap\">and/or</span> low BW. Other commonly associated factors include congenital abnormalities, multiple pregnancy, placental pathology, and intrauterine infection. (See <a href=\"#H3\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CP develops in approximately 5 to 15 percent of surviving very low birth weight (VLBW) infants. In this population, CP is often associated with the periventricular leukomalacia, intraventricular hemorrhage, <span class=\"nowrap\">and/or</span> bronchopulmonary dysplasia. (See <a href=\"#H16406295\" class=\"local\">'Prematurity'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Perinatal hypoxia <span class=\"nowrap\">and/or</span> ischemia likely accounts for only a small minority of cases of CP. (See <a href=\"#H4\" class=\"local\">'Perinatal hypoxic-ischemic injury'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stroke in the perinatal period may cause CP, and is typically manifested as spastic hemiparesis. Thromboembolism and prothrombotic disorders contribute to the etiology of this disorder. (See <a href=\"#H10\" class=\"local\">'Stroke'</a> above and <a href=\"topic.htm?path=stroke-in-the-newborn-classification-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stroke in the newborn: Classification, manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preventive measures to reduce the likelihood of CP include (see <a href=\"#H16\" class=\"local\">'Prevention'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Provision of routine prenatal care, including measures to reduce the likelihood of preterm birth. (See <a href=\"topic.htm?path=prenatal-care-initial-assessment\" class=\"medical medical_review\">&quot;Prenatal care: Initial assessment&quot;</a> and <a href=\"topic.htm?path=prenatal-care-second-and-third-trimesters\" class=\"medical medical_review\">&quot;Prenatal care: Second and third trimesters&quot;</a> and <a href=\"topic.htm?path=preterm-birth-risk-factors-and-interventions-for-risk-reduction\" class=\"medical medical_review\">&quot;Preterm birth: Risk factors and interventions for risk reduction&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Antenatal administration of <a href=\"topic.htm?path=magnesium-sulfate-pediatric-drug-information\" class=\"drug drug_pediatric\">magnesium sulfate</a> for women at risk for preterm delivery. (See <a href=\"topic.htm?path=neuroprotective-effects-of-in-utero-exposure-to-magnesium-sulfate\" class=\"medical medical_review\">&quot;Neuroprotective effects of in utero exposure to magnesium sulfate&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Supportive neuroprotective measures for neonates at risk of neurologic injury (ie, preterm VLBW infants and infants with neonatal asphyxia <span class=\"nowrap\">and/or</span> encephalopathy). (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-neonatal-encephalopathy#H8678465\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of neonatal encephalopathy&quot;, section on 'Supportive management'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Therapeutic hypothermia for term or late preterm infants with neonatal asphyxia <span class=\"nowrap\">and/or</span> encephalopathy. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-neonatal-encephalopathy#H16\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of neonatal encephalopathy&quot;, section on 'Therapeutic hypothermia'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2112081475\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Geoffrey Miller, MD, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/1\" class=\"nounderline abstract_t\">Oskoui M, Coutinho F, Dykeman J, et al. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol 2013; 55:509.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/2\" class=\"nounderline abstract_t\">Hirvonen M, Ojala R, Korhonen P, et al. Cerebral palsy among children born moderately and late preterm. Pediatrics 2014; 134:e1584.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/3\" class=\"nounderline abstract_t\">Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the &quot;common&quot; neurologic disorders? Neurology 2007; 68:326.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/4\" class=\"nounderline abstract_t\">Sellier E, Platt MJ, Andersen GL, et al. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol 2016; 58:85.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/5\" class=\"nounderline abstract_t\">Van Naarden Braun K, Doernberg N, Schieve L, et al. Birth Prevalence of Cerebral Palsy: A Population-Based Study. Pediatrics 2016; 137.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/6\" class=\"nounderline abstract_t\">Hafstr&ouml;m M, K&auml;ll&eacute;n K, Serenius F, et al. Cerebral Palsy in Extremely Preterm Infants. Pediatrics 2018; 141.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/7\" class=\"nounderline abstract_t\">Hjern A, Thorngren-Jerneck K. Perinatal complications and socio-economic differences in cerebral palsy in Sweden - a national cohort study. BMC Pediatr 2008; 8:49.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/8\" class=\"nounderline abstract_t\">Croen LA, Grether JK, Curry CJ, Nelson KB. Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents. J Pediatr 2001; 138:804.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/9\" class=\"nounderline abstract_t\">Pharoah PO, Cooke T, Rosenbloom L. Acquired cerebral palsy. Arch Dis Child 1989; 64:1013.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/10\" class=\"nounderline abstract_t\">Himmelmann K, Ahlin K, Jacobsson B, et al. Risk factors for cerebral palsy in children born at term. Acta Obstet Gynecol Scand 2011; 90:1070.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/11\" class=\"nounderline abstract_t\">Thygesen SK, Olsen M, &Oslash;stergaard JR, S&oslash;rensen HT. Respiratory distress syndrome in moderately late and late preterm infants and risk of cerebral palsy: a population-based cohort study. BMJ Open 2016; 6:e011643.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/12\" class=\"nounderline abstract_t\">Persson M, Razaz N, Tedroff K, et al. Five and 10 minute Apgar scores and risks of cerebral palsy and epilepsy: population based cohort study in Sweden. BMJ 2018.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/13\" class=\"nounderline abstract_t\">Forthun I, Wilcox AJ, Strandberg-Larsen K, et al. Maternal Prepregnancy BMI and Risk of Cerebral Palsy in Offspring. Pediatrics 2016; 138.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/14\" class=\"nounderline abstract_t\">Oleg&aring;rd R, Sabel KG, Aronsson M, et al. Effects on the child of alcohol abuse during pregnancy. Retrospective and prospective studies. Acta Paediatr Scand Suppl 1979; 275:112.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/15\" class=\"nounderline abstract_t\">O'Leary CM, Watson L, D'Antoine H, et al. Heavy maternal alcohol consumption and cerebral palsy in the offspring. Dev Med Child Neurol 2012; 54:224.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/16\" class=\"nounderline abstract_t\">Abel EL. Cerebral palsy and alcohol consumption during pregnancy: is there a connection? Alcohol Alcohol 2010; 45:592.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/17\" class=\"nounderline abstract_t\">Streja E, Miller JE, Bech BH, et al. Congenital cerebral palsy and prenatal exposure to&nbsp;self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol 2013; 209:332.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/18\" class=\"nounderline abstract_t\">Villamor E, Tedroff K, Peterson M, et al. Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy. JAMA 2017; 317:925.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/19\" class=\"nounderline abstract_t\">Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996; 75:F169.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/20\" class=\"nounderline abstract_t\">Platt MJ, Cans C, Johnson A, et al. Trends in cerebral palsy among infants of very low birthweight (&lt;1500 g) or born prematurely (&lt;32 weeks) in 16 European centres: a database study. Lancet 2007; 369:43.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/21\" class=\"nounderline abstract_t\">Robertson CM, Watt MJ, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 2007; 297:2733.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/22\" class=\"nounderline abstract_t\">Nelson KB. The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002; 8:146.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/23\" class=\"nounderline abstract_t\">Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349:1765.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/24\" class=\"nounderline abstract_t\">Strijbis EM, Oudman I, van Essen P, MacLennan AH. Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet Gynecol 2006; 107:1357.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/25\" class=\"nounderline abstract_t\">Linsell L, Malouf R, Morris J, et al. Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review. Dev Med Child Neurol 2016; 58:554.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/26\" class=\"nounderline abstract_t\">Dykes FD, Dunbar B, Lazarra A, Ahmann PA. Posthemorrhagic hydrocephalus in high-risk preterm infants: natural history, management, and long-term outcome. J Pediatr 1989; 114:611.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/27\" class=\"nounderline abstract_t\">Perlman JM. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: medicolegal issues. Pediatrics 1997; 99:851.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/28\" class=\"nounderline abstract_t\">Nelson KB. What proportion of cerebral palsy is related to birth asphyxia? J Pediatr 1988; 112:572.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/29\" class=\"nounderline abstract_t\">Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003; 102:628.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/30\" class=\"nounderline abstract_t\">Ellenberg JH, Nelson KB. The association of cerebral palsy with birth asphyxia: a definitional quagmire. Dev Med Child Neurol 2013; 55:210.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/31\" class=\"nounderline abstract_t\">Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy. Obstet Gynecol 2014; 123:896.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/32\" class=\"nounderline abstract_t\">de Vries LS, Groenendaal F. Patterns of neonatal hypoxic-ischaemic brain injury. Neuroradiology 2010; 52:555.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/33\" class=\"nounderline abstract_t\">Clancy RR, Sladky JT, Rorke LB. Hypoxic-ischemic spinal cord injury following perinatal asphyxia. Ann Neurol 1989; 25:185.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/34\" class=\"nounderline abstract_t\">Pharoah PO. Prevalence and pathogenesis of congenital anomalies in cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2007; 92:F489.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/35\" class=\"nounderline abstract_t\">Garne E, Dolk H, Kr&auml;geloh-Mann I, et al. Cerebral palsy and congenital malformations. Eur J Paediatr Neurol 2008; 12:82.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/36\" class=\"nounderline abstract_t\">Wu YW, Croen LA, Shah SJ, et al. Cerebral palsy in a term population: risk factors and neuroimaging findings. Pediatrics 2006; 118:690.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/37\" class=\"nounderline abstract_t\">Rankin J, Cans C, Garne E, et al. Congenital anomalies in children with cerebral palsy: a population-based record linkage study. Dev Med Child Neurol 2010; 52:345.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/38\" class=\"nounderline abstract_t\">Freeman JM, Nelson KB. Intrapartum asphyxia and cerebral palsy. Pediatrics 1988; 82:240.</a></li><li class=\"breakAll\">Brann AW. Factors during neonatal life that influence brain disorder. In: Prenatal and Perinatal Factors Associated with Brain Disorders (NIH Pub. No. 85-1149), Freeman JM (Ed), US Government Printing Office, Washington, DC 1998. p.263.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/40\" class=\"nounderline abstract_t\">Felix JF, Badawi N, Kurinczuk JJ, et al. Birth defects in children with newborn encephalopathy. Dev Med Child Neurol 2000; 42:803.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/41\" class=\"nounderline abstract_t\">Wood JW, Johnson KG, Omori Y. In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics 1967; 39:385.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/42\" class=\"nounderline abstract_t\">Dekaban AS. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I. J Nucl Med 1968; 9:471.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/43\" class=\"nounderline abstract_t\">Brent RL, Beckman DA. Environmental teratogens. Bull N Y Acad Med 1990; 66:123.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/44\" class=\"nounderline abstract_t\">Rorke LB. A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J Neuropathol Exp Neurol 1994; 53:105.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/45\" class=\"nounderline abstract_t\">Hilburger AC, Willis JK, Bouldin E, Henderson-Tilton A. Familial schizencephaly. Brain Dev 1993; 15:234.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/46\" class=\"nounderline abstract_t\">Haverkamp F, Zerres K, Ostertun B, et al. Familial schizencephaly: further delineation of a rare disorder. J Med Genet 1995; 32:242.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/47\" class=\"nounderline abstract_t\">Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996; 14:357.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/48\" class=\"nounderline abstract_t\">Dobyns WB, Andermann E, Andermann F, et al. X-linked malformations of neuronal migration. Neurology 1996; 47:331.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/49\" class=\"nounderline abstract_t\">Barkovich AJ, Kuzniecky RI, Dobyns WB, et al. A classification scheme for malformations of cortical development. Neuropediatrics 1996; 27:59.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/50\" class=\"nounderline abstract_t\">Dodge NN, Dobyns WB. Agenesis of the corpus callosum and Dandy-Walker malformation associated with hemimegalencephaly in the sebaceous nevus syndrome. Am J Med Genet 1995; 56:147.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/51\" class=\"nounderline abstract_t\">Schaefer GB. Genetics considerations in cerebral palsy. Semin Pediatr Neurol 2008; 15:21.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/52\" class=\"nounderline abstract_t\">Moreno-De-Luca A, Ledbetter DH, Martin CL. Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies. Lancet Neurol 2012; 11:283.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/53\" class=\"nounderline abstract_t\">MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol 2015; 213:779.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/54\" class=\"nounderline abstract_t\">Bundey S, Griffiths MI. Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol 1977; 19:179.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/55\" class=\"nounderline abstract_t\">Hemminki K, Sundquist K, Li X. Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden. Twin Res Hum Genet 2006; 9:580.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/56\" class=\"nounderline abstract_t\">Toll&aring;nes MC, Wilcox AJ, Lie RT, Moster D. Familial risk of cerebral palsy: population based cohort study. BMJ 2014; 349:g4294.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/57\" class=\"nounderline abstract_t\">McMichael G, Bainbridge MN, Haan E, et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 2015; 20:176.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/58\" class=\"nounderline abstract_t\">Segel R, Ben-Pazi H, Zeligson S, et al. Copy number variations in cryptogenic cerebral palsy. Neurology 2015; 84:1660.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/59\" class=\"nounderline abstract_t\">Kuroda MM, Weck ME, Sarwark JF, et al. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119:306.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/60\" class=\"nounderline abstract_t\">Lien E, Andersen G, Bao Y, et al. Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E. Acta Paediatr 2015; 104:701.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/61\" class=\"nounderline abstract_t\">Gibson CS, MacLennan AH, Hague WM, et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol 2005; 193:1437.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/62\" class=\"nounderline abstract_t\">O'Callaghan ME, Maclennan AH, Gibson CS, et al. Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. Pediatrics 2012; 129:e414.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/63\" class=\"nounderline abstract_t\">Gibson CS, MacLennan AH, Goldwater PN, et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194:674.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/64\" class=\"nounderline abstract_t\">Gibson CS, Maclennan AH, Dekker GA, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122:1079.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/65\" class=\"nounderline abstract_t\">Parodi L, Fenu S, Stevanin G, Durr A. Hereditary spastic paraplegia: More than an upper motor neuron disease. Rev Neurol (Paris) 2017; 173:352.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/66\" class=\"nounderline abstract_t\">Sch&uuml;le R, Wiethoff S, Martus P, et al. Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients. Ann Neurol 2016; 79:646.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/67\" class=\"nounderline abstract_t\">Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ 1993; 307:1239.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/68\" class=\"nounderline abstract_t\">Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis Child Fetal Neonatal Ed 1996; 75:F174.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/69\" class=\"nounderline abstract_t\">Larroche JC, Droull&eacute; P, Delezoide AL, et al. Brain damage in monozygous twins. Biol Neonate 1990; 57:261.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/70\" class=\"nounderline abstract_t\">Scheller JM, Nelson KB. Twinning and neurologic morbidity. Am J Dis Child 1992; 146:1110.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/71\" class=\"nounderline abstract_t\">Weig SG, Marshall PC, Abroms IF, Gauthier NS. Patterns of cerebral injury and clinical presentation in the vascular disruptive syndrome of monozygotic twins. Pediatr Neurol 1995; 13:279.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/72\" class=\"nounderline abstract_t\">Bonellie SR, Currie D, Chalmers J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol 2005; 47:587.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/73\" class=\"nounderline abstract_t\">Bejar R, Vigliocco G, Gramajo H, et al. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol 1990; 162:1230.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/74\" class=\"nounderline abstract_t\">Pharoah PO. Twins and cerebral palsy. Acta Paediatr Suppl 2001; 90:6.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/75\" class=\"nounderline abstract_t\">Pharoah PO. Cerebral palsy in the surviving twin associated with infant death of the co-twin. Arch Dis Child Fetal Neonatal Ed 2001; 84:F111.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/76\" class=\"nounderline abstract_t\">Nelson KB. Prenatal origin of hemiparetic cerebral palsy: how often and why? Pediatrics 1991; 88:1059.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/77\" class=\"nounderline abstract_t\">Barmada MA, Moossy J, Shuman RM. Cerebral infarcts with arterial occlusion in neonates. Ann Neurol 1979; 6:495.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/78\" class=\"nounderline abstract_t\">Levy SR, Abroms IF, Marshall PC, Rosquete EE. Seizures and cerebral infarction in the full-term newborn. Ann Neurol 1985; 17:366.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/79\" class=\"nounderline abstract_t\">Wiklund LM, Uvebrant P. Hemiplegic cerebral palsy: correlation between CT morphology and clinical findings. Dev Med Child Neurol 1991; 33:512.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/80\" class=\"nounderline abstract_t\">Kuban KC, Leviton A. Cerebral palsy. N Engl J Med 1994; 330:188.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/81\" class=\"nounderline abstract_t\">Hanigan WC, Powell FC, Miller TC, Wright RM. Symptomatic intracranial hemorrhage in full-term infants. Childs Nerv Syst 1995; 11:698.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/82\" class=\"nounderline abstract_t\">Gradnitzer E, Urlesberger B, Maurer U, et al. [Cerebral hemorrhage in term newborn infants--an analysis of 10 years (1989-1999)]. Wien Med Wochenschr 2002; 152:9.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/83\" class=\"nounderline abstract_t\">Roland EH, Flodmark O, Hill A. Thalamic hemorrhage with intraventricular hemorrhage in the full-term newborn. Pediatrics 1990; 85:737.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/84\" class=\"nounderline abstract_t\">Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278:207.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/85\" class=\"nounderline abstract_t\">Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child 1985; 139:1031.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/86\" class=\"nounderline abstract_t\">Wu YW, Escobar GJ, Grether JK, et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003; 290:2677.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/87\" class=\"nounderline abstract_t\">Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000; 284:1417.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/88\" class=\"nounderline abstract_t\">Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002; 8:25.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/89\" class=\"nounderline abstract_t\">Ahlin K, Himmelmann K, Hagberg G, et al. Cerebral palsy and perinatal infection in children born at term. Obstet Gynecol 2013; 122:41.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-etiology-and-prevention-of-cerebral-palsy/abstract/90\" class=\"nounderline abstract_t\">O'Shea TM. Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 2002; 8:135.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6173 Version 34.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H17\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H338437633\" id=\"outline-link-H338437633\">Prevalence</a></li><li><a href=\"#H338437639\" id=\"outline-link-H338437639\">Risk factors</a></li><li><a href=\"#H338437646\" id=\"outline-link-H338437646\">Trends over time</a></li></ul></li><li><a href=\"#H3\" id=\"outline-link-H3\">ETIOLOGY</a><ul><li><a href=\"#H16406295\" id=\"outline-link-H16406295\">Prematurity</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Perinatal hypoxic-ischemic injury</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Congenital abnormalities</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Genetic susceptibility</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Multiple births</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Stroke</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Intracranial hemorrhage</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Intrauterine infection</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Acquired postnatal causes</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">PREVENTION</a><ul><li><a href=\"#H16405152\" id=\"outline-link-H16405152\">Antenatal measures</a><ul><li><a href=\"#H16405165\" id=\"outline-link-H16405165\">- Magnesium sulfate</a></li></ul></li><li><a href=\"#H4234399981\" id=\"outline-link-H4234399981\">Intrapartum measures</a></li><li><a href=\"#H16405158\" id=\"outline-link-H16405158\">Postnatal measures</a><ul><li><a href=\"#H16405196\" id=\"outline-link-H16405196\">- Supportive measures</a></li><li><a href=\"#H16405171\" id=\"outline-link-H16405171\">- Therapeutic hypothermia</a></li></ul></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">SUMMARY</a></li><li><a href=\"#H2112081475\" id=\"outline-link-H2112081475\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/6173|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/100474\" class=\"graphic graphic_diagnosticimage\">- Brain injury patterns of neonatal HIE on MRI</a></li></ul></li><li><div id=\"PEDS/6173|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/102940\" class=\"graphic graphic_table\">- Risk factors for CP</a></li><li><a href=\"image.htm?imageKey=PEDS/74533\" class=\"graphic graphic_table\">- Cerebral palsy subtypes</a></li><li><a href=\"image.htm?imageKey=NEURO/96192\" class=\"graphic graphic_table\">- Peripartum or intrapartum hypoxic-ischemic event</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-toxic-metabolic-encephalopathy-in-children\" class=\"medical medical_review\">Acute toxic-metabolic encephalopathy in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-meningitis-in-the-neonate-neurologic-complications\" class=\"medical medical_review\">Bacterial meningitis in the neonate: Neurologic complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=child-abuse-evaluation-and-diagnosis-of-abusive-head-trauma-in-infants-and-children\" class=\"medical medical_review\">Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-classification-of-cerebral-palsy\" class=\"medical medical_review\">Clinical features and classification of cerebral palsy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-neonatal-encephalopathy\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of neonatal encephalopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants\" class=\"medical medical_review\">Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-zika-virus-infection-clinical-features-evaluation-and-management-of-the-neonate\" class=\"medical medical_review\">Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-cytogenetic-abnormalities\" class=\"medical medical_review\">Congenital cytogenetic abnormalities</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-cytomegalovirus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital cytomegalovirus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drowning-submersion-injuries\" class=\"medical medical_review\">Drowning (submersion injuries)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-and-pathogenesis-of-neonatal-encephalopathy\" class=\"medical medical_review\">Etiology and pathogenesis of neonatal encephalopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-clinical-manifestations-evaluation-and-management-of-neonatal-shock\" class=\"medical medical_review\">Etiology, clinical manifestations, evaluation, and management of neonatal shock</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-diagnosis-of-cerebral-palsy\" class=\"medical medical_review\">Evaluation and diagnosis of cerebral palsy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fluid-and-electrolyte-therapy-in-newborns\" class=\"medical medical_review\">Fluid and electrolyte therapy in newborns</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=germinal-matrix-hemorrhage-and-intraventricular-hemorrhage-gmh-ivh-in-the-newborn-pathogenesis-clinical-presentation-and-diagnosis\" class=\"medical medical_review\">Germinal matrix hemorrhage and intraventricular hemorrhage (GMH-IVH) in the newborn: Pathogenesis, clinical presentation, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=germinal-matrix-hemorrhage-and-intraventricular-hemorrhage-gmh-ivh-in-the-newborn-prevention-management-and-complications\" class=\"medical medical_review\">Germinal matrix hemorrhage and intraventricular hemorrhage (GMH-IVH) in the newborn: Prevention, management, and complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hereditary-spastic-paraplegia\" class=\"medical medical_review\">Hereditary spastic paraplegia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inborn-errors-of-metabolism-metabolic-emergencies\" class=\"medical medical_review\">Inborn errors of metabolism: Metabolic emergencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ischemic-stroke-in-children-and-young-adults-etiology-and-clinical-features\" class=\"medical medical_review\">Ischemic stroke in children and young adults: Etiology and clinical features</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-and-outcome-of-neonatal-hypoglycemia\" class=\"medical medical_review\">Management and outcome of neonatal hypoglycemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-and-outcome-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">Management and outcome of sepsis in term and late preterm infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-and-prognosis-of-cerebral-palsy\" class=\"medical medical_review\">Management and prognosis of cerebral palsy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-normal-labor-and-delivery\" class=\"medical medical_review\">Management of normal labor and delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mechanical-ventilation-in-neonates\" class=\"medical medical_review\">Mechanical ventilation in neonates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-hyperglycemia\" class=\"medical medical_review\">Neonatal hyperglycemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neuroprotective-effects-of-in-utero-exposure-to-magnesium-sulfate\" class=\"medical medical_review\">Neuroprotective effects of in utero exposure to magnesium sulfate</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=outcome-of-infants-with-bronchopulmonary-dysplasia\" class=\"medical medical_review\">Outcome of infants with bronchopulmonary dysplasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-torch-infections\" class=\"medical medical_review\">Overview of TORCH infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postnatal-use-of-corticosteroids-in-bronchopulmonary-dysplasia\" class=\"medical medical_review\">Postnatal use of corticosteroids in bronchopulmonary dysplasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prenatal-care-initial-assessment\" class=\"medical medical_review\">Prenatal care: Initial assessment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prenatal-care-second-and-third-trimesters\" class=\"medical medical_review\">Prenatal care: Second and third trimesters</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prenatal-diagnosis-of-cns-anomalies-other-than-neural-tube-defects-and-ventriculomegaly\" class=\"medical medical_review\">Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preterm-birth-risk-factors-and-interventions-for-risk-reduction\" class=\"medical medical_review\">Preterm birth: Risk factors and interventions for risk reduction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prothrombin-g20210a-mutation\" class=\"medical medical_review\">Prothrombin G20210A mutation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stroke-in-the-newborn-classification-manifestations-and-diagnosis\" class=\"medical medical_review\">Stroke in the newborn: Classification, manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-genodermatoses\" class=\"medical medical_review\">The genodermatoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-bacterial-sepsis-in-the-preterm-infant-less-than34-weeks-gestation\" class=\"medical medical_review\">Treatment and prevention of bacterial sepsis in the preterm infant (&lt;34 weeks gestation)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-neonatal-seizures\" class=\"medical medical_review\">Treatment of neonatal seizures</a></li></ul></div></div>","javascript":null}